Answers are grounded in this paper and cite their sources.
Rifampin has limited use in monotherapy because of the rapid development of resistance. In combination therapy with a variety of antimicrobials, it has many applications for treatment of serious infections.
No takes yet. Share an insight, caveat, or question.
Ann M. Loeffler (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: